rfhg_218864.1

Basic information about the TSS

---

TSS ID: rfhg_218864.1 TSS ID(Version3): hg_237928.1 hg_186718.1 hg_186719.1 hg_186720.1 Species: human Chr: chr20		Start: 23637719 End: 23638017 Strand: -
Source datasets	DRA000914|ENCODE|PRJDB5282|PRJNA615891|PRJNA548673 |PRJNA401781|DRA013844|PRJNA4843412
Protocol	CAGE|C1CAGE|TIF-seq2|SLIC_CAGE|ReCappable-seq|oligo_capping |NETCAGE
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3288216,EH38E2104376)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000398411.5:0 ENST00000376925.8:0 BX647523:0 BC013083:0 BC110305:0 GQ472213:0 X05607:0 DQ891439:0 BT006839:0 CR541988:0 AK312213:0 EU176584:0 CR542018:0 AB590227:0 AB587083:0 GeneID: 1471 HGNC/MGI_ID: HGNC:2475 UniProt_ID: A0A0K0K1J1 E9RH26 Nearer transcript ids and distances: LF205942:-184 MA441519:-184 ENST00000398409.1:-456 view more...

Gene_name: cystatin C Gene_symbol: CST3 Gene_synonyms: Gene_source: HGNC:2475

TATA-Box annotation

---

Distance to TSS:	87
Nearest PromoterID:	NM_000099
Entrez ID:	1471
Nearest Unigene:	Hs.304682
Nearest Refseq:	NM_000099
Nearest Ensembl:	ENSG00000101439
Gene Name:	cystatin C
Gene Alias:	ARMD11|HEL-S-2
Gene Type:	protein-coding
CpG%:	0.117450
GC%:	0.749164
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CST3 p2@CST3 p3@CST3
Sample		p1@CST3	p2@CST3	p3@CST3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	65.65	1.36	30.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	73.04	1.82	32.78
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	69.83	0.96	30.48
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	61.96	0.42	29.52
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	57.37	0.90	28.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	59.50	1.94	26.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	83.45	1.96	29.63
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	76.30	1.21	30.28
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	79.08	2.14	29.49
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.75	1.16	24.92
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.30	2.02	16.98
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.17	0.41	12.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	243.40	5.96	58.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	207.18	6.16	51.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	213.63	6.81	54.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	273.12	4.78	59.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	264.71	5.02	56.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	256.04	7.17	43.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	224.46	5.33	43.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	213.63	2.71	51.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	235.36	5.88	53.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	197.83	3.97	48.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	221.81	5.04	47.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	233.20	4.13	56.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	215.16	4.39	56.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	220.93	5.06	60.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	231.87	8.24	39.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	225.38	6.13	54.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	213.05	4.36	52.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	221.32	6.15	48.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	233.63	6.49	53.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	217.07	6.06	56.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	232.13	7.17	47.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	226.13	5.11	44.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	230.18	5.80	51.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	210.59	5.94	58.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	214.39	4.70	57.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	235.74	4.84	58.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	233.10	5.94	54.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	198.53	4.56	48.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	212.91	6.12	51.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	199.54	5.71	41.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	195.29	4.22	56.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	206.47	5.42	55.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	184.71	3.61	57.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	177.51	3.02	43.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	216.16	6.00	60.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	181.81	6.56	47.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	199.88	3.11	61.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	190.27	4.45	44.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	189.99	4.51	55.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	190.80	6.67	60.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	196.59	4.61	53.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	182.26	4.64	69.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	55.37	0.84	32.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	99.66	4.59	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	183.77	4.54	82.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	172.15	5.46	73.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	99.01	2.51	47.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	176.26	5.64	54.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	200.20	6.17	72.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	74.84	4.78	35.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	92.76	2.38	47.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	143.94	4.87	58.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	159.03	3.19	71.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	177.94	2.93	75.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	146.78	4.46	46.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	131.82	2.81	62.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	122.21	3.31	53.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	194.27	6.81	115.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	185.28	6.73	100.59
Adipocyte - breast, donor1	11376-118A8	1176.48	25.18	91.39
Adipocyte - breast, donor2	11327-117E4	946.36	18.29	71.23
Adipocyte - omental, donor1	11473-119C6	1382.71	31.30	107.51
Adipocyte - omental, donor2	11474-119C7	1237.85	28.40	67.27
Adipocyte - omental, donor3	11475-119C8	1910.04	32.49	87.41
Adipocyte - perirenal, donor1	11476-119C9	1209.63	29.99	75.28
Adipocyte - subcutaneous, donor1	11259-116F8	442.00	14.29	80.26
Adipocyte - subcutaneous, donor2	11336-117F4	1017.51	30.71	88.07
Adipocyte - subcutaneous, donor3	11408-118E4	1237.46	30.58	153.62
Adipocyte differentiation, day04, donor1	13019-139D4	285.93	8.80	49.28
Adipocyte differentiation, day04, donor2	13022-139D7	209.51	10.55	29.08
Adipocyte differentiation, day04, donor3	13025-139E1	248.67	7.25	36.52
Adipocyte differentiation, day04, donor4	13028-139E4	279.80	10.58	41.15
Adipocyte differentiation, day08, donor1	13020-139D5	311.44	7.48	33.06
Adipocyte differentiation, day08, donor2	13023-139D8	374.72	17.75	34.53
Adipocyte differentiation, day08, donor3	13026-139E2	285.79	7.46	28.79
Adipocyte differentiation, day08, donor4	13029-139E5	336.64	9.46	24.48
Adipocyte differentiation, day12, donor1	13021-139D6	547.31	14.14	46.16
Adipocyte differentiation, day12, donor2	13024-139D9	465.41	13.31	45.46
Adipocyte differentiation, day12, donor3	13027-139E3	392.37	8.84	28.14
Adipocyte differentiation, day12, donor4	13030-139E6	353.80	5.18	23.75
Alveolar Epithelial Cells, donor1	11510-119G7	226.74	7.29	14.36
Alveolar Epithelial Cells, donor2	11590-120G6	263.92	5.74	16.85
Alveolar Epithelial Cells, donor3	11671-122G6	269.55	3.59	22.76
Amniotic Epithelial Cells, donor1	11533-120A3	170.73	5.58	28.60
Amniotic Epithelial Cells, donor2	11613-122A2	224.25	5.02	58.57
Amniotic Epithelial Cells, donor3	11694-123A2	184.70	7.19	44.17
Anulus Pulposus Cell, donor1	11248-116E6	610.81	13.85	55.95
Anulus Pulposus Cell, donor2	11463-119B5	765.33	12.98	38.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	153.66	6.74	21.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	155.86	4.34	23.01
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	175.50	4.28	29.96
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	180.25	6.28	20.92
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	128.99	2.53	20.23
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	137.95	5.94	30.36
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	143.60	3.57	24.04
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	140.29	5.34	19.42
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	143.72	2.97	23.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	138.23	4.90	21.09
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	128.44	3.63	22.50
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	136.66	10.03	23.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	180.88	5.60	27.68
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	161.05	2.73	21.84
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	143.70	4.98	31.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	157.52	4.29	25.72
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	136.98	6.05	26.83
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	152.09	7.75	21.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	151.20	5.85	28.29
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	138.82	4.98	25.21
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	186.11	8.41	24.01
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	159.31	3.54	21.24
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	152.66	5.15	24.70
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	163.60	16.78	25.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	147.57	4.37	24.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	151.78	7.59	31.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	147.79	4.85	27.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	147.64	5.70	25.08
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	144.08	8.12	27.15
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	158.98	6.19	26.84
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	129.97	2.35	27.21
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	155.31	4.50	20.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	167.66	5.71	32.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	140.97	5.85	19.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	145.42	7.23	21.38
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	182.95	4.75	42.77
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	154.09	4.07	23.90
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	136.51	5.60	23.94
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	153.76	3.18	27.32
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	136.36	4.32	25.89
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	151.78	3.39	23.07
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	161.52	6.09	26.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	148.32	4.72	28.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	150.03	6.95	22.38
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	157.51	6.95	37.06
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	154.22	6.34	25.35
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	146.44	5.57	22.94
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	168.47	4.81	27.68
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	148.71	2.19	24.79
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	142.99	6.21	28.05
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	150.47	2.55	20.40
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	143.39	5.85	25.17
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	161.02	6.61	22.30
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	166.16	7.04	24.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	144.84	4.30	20.08
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	134.37	7.32	27.27
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	160.21	6.10	21.36
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	114.10	2.77	28.25
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	137.96	6.62	25.69
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	158.10	9.81	31.26
Astrocyte - cerebellum, donor1	11500-119F6	276.34	14.62	12.90
Astrocyte - cerebellum, donor2	11580-120F5	354.99	16.43	22.42
Astrocyte - cerebellum, donor3	11661-122F5	333.71	12.38	38.38
Astrocyte - cerebral cortex, donor1	11235-116D2	183.01	4.18	36.60
Astrocyte - cerebral cortex, donor2	11316-117D2	167.76	4.85	33.65
Astrocyte - cerebral cortex, donor3	11392-118C6	169.74	4.92	36.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	12.62	0.92	3.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13.03	0.63	4.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.88	0.57	3.07
Basophils, donor1	12241-129G9	964.53	86.31	56.23
Basophils, donor2	12242-129H1	513.05	48.35	32.83
Basophils, donor3	12243-129H2	1610.21	124.80	71.00
Bronchial Epithelial Cell, donor1	11511-119G8	495.67	10.78	24.58
Bronchial Epithelial Cell, donor2	11591-120G7	604.86	13.26	37.49
Bronchial Epithelial Cell, donor3	11672-122G7	695.84	14.35	57.39
Bronchial Epithelial Cell, donor4	11453-119A4	282.44	6.28	14.44
Bronchial Epithelial Cell, donor5	11457-119A8	325.65	5.41	16.22
Bronchial Epithelial Cell, donor6	11461-119B3	246.87	5.76	17.27
Bronchial Epithelial Cell, donor7	11769-123I5	325.70	7.20	25.01
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	135.58	34.54	31.98
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	20.68
CD14+ Monocytes, donor1	11224-116B9	786.72	117.78	43.96
CD14+ Monocytes, donor2	11305-117B9	570.72	32.11	37.86
CD14+ Monocytes, donor3	11381-118B4	1467.16	104.50	79.47
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	2257.84	67.36	121.43
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	2027.29	57.62	90.60
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2202.23	57.20	71.34
CD14+ monocytes - mock treated, donor1	11863-125A9	979.90	41.05	67.07
CD14+ monocytes - mock treated, donor2	11873-125C1	1734.72	109.53	62.16
CD14+ monocytes - mock treated, donor3	11883-125D2	1154.38	60.88	60.41
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	694.53	29.80	43.19
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1313.54	86.67	44.99
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	889.32	39.42	42.64
CD14+ monocytes - treated with BCG, donor1	11860-125A6	799.45	40.14	57.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1631.64	99.17	64.99
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1227.87	79.22	64.20
CD14+ monocytes - treated with Candida, donor1	11868-125B5	506.65	22.94	34.42
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1118.36	75.51	57.03
CD14+ monocytes - treated with Candida, donor3	11888-125D7	722.19	33.28	39.94
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	757.87	37.63	51.47
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1432.75	100.17	46.49
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	896.30	48.93	40.60
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	733.94	36.83	48.04
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1288.01	104.28	46.37
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	723.65	30.55	34.92
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	887.94	40.35	50.57
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2190.52	130.85	87.75
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1341.16	57.23	68.59
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	633.25	29.94	42.07
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1232.93	79.96	44.74
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	698.45	31.59	34.66
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	784.16	35.92	45.69
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1824.93	124.88	62.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1246.52	72.86	68.54
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	648.22	36.85	38.49
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1170.82	100.14	41.26
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	676.72	45.47	31.32
CD14+CD16+ Monocytes, donor1	11789-124B7	3000.93	387.98	108.98
CD14+CD16+ Monocytes, donor2	11801-124D1	1692.03	196.58	69.53
CD14+CD16+ Monocytes, donor3	11912-125G4	3891.94	269.04	131.05
CD14+CD16- Monocytes, donor1	11788-124B6	2730.43	356.14	126.45
CD14+CD16- Monocytes, donor2	11799-124C8	1144.27	191.24	81.21
CD14+CD16- Monocytes, donor3	11910-125G2	1923.33	165.00	87.40
CD14-CD16+ Monocytes, donor1	11790-124B8	2971.51	359.80	151.06
CD14-CD16+ Monocytes, donor2	11800-124C9	1132.30	129.76	66.97
CD14-CD16+ Monocytes, donor3	11911-125G3	2823.42	237.92	115.38
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	34.58	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	113.54	11.73	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	20.37	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.10	1.40	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	42.36	3.92	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	7.91	2.64
CD19+ B Cells, donor1	11544-120B5	9.04	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	43.53	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	16.66	0.50	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	16.57	1.62	5.25
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.38	0.80	5.59
CD34+ Progenitors, donor1	11545-120B6	44.18	8.03	7.03
CD34+ Progenitors, donor2	11625-122B5	139.89	10.67	10.11
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	200.28	18.79	25.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	272.16	24.58	34.05
CD4+ T Cells, donor1	11225-116C1	8.21	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	6.12	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	32.02	1.83	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.51	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.86	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.29	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.97	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.62	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.67	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.75	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.19	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.52	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	2.17	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	86.60	3.96	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	16.62	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	438.38	24.09	6.09
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	285.88	12.27	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	178.64	18.48	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	220.24	14.32	9.31
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	72.02	4.15	8.31
CD8+ T Cells, donor1	11226-116C2	1.96	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	1.50	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	5.05	0.76	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.98	0.69	11.47
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	44.81	1.68	10.78
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.05	1.37	10.94
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	48.03	2.10	15.61
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	50.64	2.16	15.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	49.57	1.82	13.42
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	48.24	2.17	15.86
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	47.38	2.37	15.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	50.89	1.88	14.54
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	56.15	2.11	14.79
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	58.39	2.61	14.82
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.29	1.07	17.58
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	43.34	0.88	9.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	50.55	3.19	8.20
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.24	0.75	7.46
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.86	3.60	17.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	45.17	2.01	17.26
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	49.73	1.18	14.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	36.13	1.90	14.26
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.45	2.77	18.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	38.47	2.24	10.90
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	55.46	0.00	15.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	38.23	1.18	12.22
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	45.38	1.51	12.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	37.74	0.00	10.44
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	43.36	0.70	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	1308.66	40.21	29.24
Cardiac Myocyte, donor2	11605-120I3	805.86	29.15	40.52
Cardiac Myocyte, donor3	11686-122I3	691.17	16.42	60.82
Chondrocyte - de diff, donor1	11261-116G1	275.95	6.59	34.32
Chondrocyte - de diff, donor2	11338-117F6	237.04	4.98	55.08
Chondrocyte - de diff, donor3	11410-118E6	292.18	11.49	79.42
Chondrocyte - re diff, donor2	11339-117F7	318.71	53.72	56.40
Chondrocyte - re diff, donor3	11411-118E7	365.58	21.84	85.33
Ciliary Epithelial Cells, donor1	11242-116D9	257.86	12.85	33.85
Ciliary Epithelial Cells, donor2	11323-117D9	205.86	26.29	31.42
Ciliary Epithelial Cells, donor3	11399-118D4	275.94	11.86	33.45
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	1614.94	10.18	82.90
Corneal Epithelial Cells, donor1	11526-119I5	466.59	10.98	27.89
Corneal Epithelial Cells, donor2	11606-120I4	466.42	3.41	25.03
Corneal Epithelial Cells, donor3	11687-122I4	396.74	4.60	27.61
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9475.66	25.26	44.08
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8060.92	26.18	64.97
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	14058.16	37.96	65.56
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6493.42	25.38	67.71
Dendritic Cells - plasmacytoid, donor1	11228-116C4	841.80	48.17	69.69
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1380.17	75.08	79.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1501.68	77.43	45.49
Endothelial Cells - Aortic, donor0	11207-116A1	178.11	5.67	26.35
Endothelial Cells - Aortic, donor1	11263-116G3	288.69	8.80	22.30
Endothelial Cells - Aortic, donor2	11340-117F8	342.18	10.75	26.30
Endothelial Cells - Aortic, donor3	11412-118E8	248.89	9.44	18.48
Endothelial Cells - Artery, donor1	11264-116G4	324.91	13.38	35.49
Endothelial Cells - Artery, donor2	11341-117F9	235.75	8.94	32.70
Endothelial Cells - Artery, donor3	11413-118E9	223.87	11.04	23.49
Endothelial Cells - Lymphatic, donor1	11236-116D3	422.03	5.98	20.17
Endothelial Cells - Lymphatic, donor2	11317-117D3	519.99	6.09	17.04
Endothelial Cells - Lymphatic, donor3	11393-118C7	199.87	3.38	11.84
Endothelial Cells - Microvascular, donor1	11265-116G5	221.66	7.43	16.34
Endothelial Cells - Microvascular, donor2	11342-117G1	212.43	4.69	17.70
Endothelial Cells - Microvascular, donor3	11414-118F1	168.30	1.70	29.35
Endothelial Cells - Thoracic, donor1	11266-116G6	183.25	3.20	6.00
Endothelial Cells - Thoracic, donor2	11343-117G2	296.65	11.01	30.92
Endothelial Cells - Umbilical vein, donor1	11243-116E1	286.76	5.47	19.38
Endothelial Cells - Umbilical vein, donor2	11324-117E1	170.99	3.04	12.82
Endothelial Cells - Umbilical vein, donor3	11400-118D5	163.28	4.64	13.43
Endothelial Cells - Vein, donor1	11267-116G7	243.43	10.24	20.48
Endothelial Cells - Vein, donor2	11344-117G3	279.40	13.27	23.05
Endothelial Cells - Vein, donor3	11416-118F3	357.35	11.46	28.89
Eosinophils, donor1	12244-129H3	152.47	0.00	15.25
Eosinophils, donor2	12245-129H4	84.16	4.95	6.60
Eosinophils, donor3	12246-129H5	135.54	3.57	17.83
Esophageal Epithelial Cells, donor1	11507-119G4	369.67	7.57	15.15
Esophageal Epithelial Cells, donor2	11587-120G3	451.40	0.00	22.88
Esophageal Epithelial Cells, donor3	11668-122G3	699.56	0.00	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	343.19	15.19	87.44
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	246.46	11.28	53.32
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.78	2.28	29.90
Fibroblast - Aortic Adventitial, donor1	11245-116E3	235.04	7.40	30.56
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	192.15	6.00	14.74
Fibroblast - Aortic Adventitial, donor2	11326-117E3	263.25	12.02	43.88
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	747.79	26.61	49.01
Fibroblast - Aortic Adventitial, donor3	11401-118D6	308.28	10.63	36.87
Fibroblast - Cardiac, donor1	11268-116G8	318.90	7.71	48.54
Fibroblast - Cardiac, donor2	11345-117G4	159.93	5.31	25.01
Fibroblast - Cardiac, donor3	11417-118F4	277.27	14.35	54.41
Fibroblast - Cardiac, donor4	11452-119A3	1724.38	19.40	33.95
Fibroblast - Cardiac, donor5	11456-119A7	258.50	6.47	15.48
Fibroblast - Cardiac, donor6	11460-119B2	408.70	8.79	16.37
Fibroblast - Choroid Plexus, donor1	11492-119E7	508.23	15.81	17.55
Fibroblast - Choroid Plexus, donor2	11572-120E6	420.64	17.26	35.38
Fibroblast - Choroid Plexus, donor3	11653-122E6	218.25	8.79	29.30
Fibroblast - Conjunctival, donor1	11531-120A1	311.13	8.30	29.98
Fibroblast - Conjunctival, donor3	11692-122I9	819.53	10.35	90.23
Fibroblast - Dermal, donor1	11269-116G9	741.91	17.14	42.26
Fibroblast - Dermal, donor2	11346-117G5	387.25	14.15	30.19
Fibroblast - Dermal, donor3	11418-118F5	915.59	15.47	66.49
Fibroblast - Dermal, donor4	11450-119A1	152.61	4.52	12.32
Fibroblast - Dermal, donor5	11454-119A5	167.65	4.36	15.88
Fibroblast - Dermal, donor6	11458-119A9	172.17	4.55	15.11
Fibroblast - Gingival, donor1	11237-116D4	589.08	9.79	27.49
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	222.70	6.29	46.11
Fibroblast - Gingival, donor2	11318-117D4	273.19	8.17	28.60
Fibroblast - Gingival, donor3	11394-118C8	661.72	11.41	47.28
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	228.56	10.39	69.61
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	208.10	5.81	64.31
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	116.92	3.59	20.42
Fibroblast - Gingival, donor6 (control)	11922-125H5	134.69	6.22	19.88
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	139.74	5.65	31.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	163.50	4.68	26.47
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	148.63	3.82	18.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	134.48	4.39	24.24
Fibroblast - Gingival, donor9 (control)	11927-125I1	247.40	10.71	82.03
Fibroblast - Lung, donor1	11270-116H1	375.18	19.03	50.30
Fibroblast - Lung, donor2	11347-117G6	417.80	7.46	10.45
Fibroblast - Lung, donor3	11419-118F6	548.48	40.94	71.96
Fibroblast - Lymphatic, donor1	11506-119G3	1454.46	39.99	19.16
Fibroblast - Lymphatic, donor2	11586-120G2	1423.80	20.98	8.39
Fibroblast - Lymphatic, donor3	11667-122G2	683.18	28.27	46.18
Fibroblast - Mammary, donor1	11540-120B1	782.30	28.01	42.63
Fibroblast - Mammary, donor2	11620-122A9	475.31	59.91	55.92
Fibroblast - Mammary, donor3	11701-123A9	994.70	11.91	59.56
Fibroblast - Periodontal Ligament, donor1	11238-116D5	229.08	4.07	23.08
Fibroblast - Periodontal Ligament, donor2	11319-117D5	225.85	6.83	24.57
Fibroblast - Periodontal Ligament, donor3	11395-118C9	366.27	7.04	22.34
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	98.84	5.34	25.19
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	159.29	3.51	47.25
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	239.37	8.35	67.84
Fibroblast - Pulmonary Artery, donor1	11250-116E8	375.70	8.40	36.14
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	423.86	11.79	24.99
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	409.61	12.03	38.09
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	415.92	9.88	59.70
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	129.98	5.75	11.51
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	235.17	12.26	54.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	197.48	6.70	34.29
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	259.34	9.33	31.89
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	180.71	6.48	26.23
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	161.21	5.82	11.14
Fibroblast - skin normal, donor1	11553-120C5	275.16	9.02	49.22
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	204.32	6.82	23.46
Fibroblast - skin normal, donor2	11561-120D4	183.14	6.93	18.99
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	141.14	5.14	11.18
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	213.83	6.79	48.63
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	399.17	9.40	36.93
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	280.15	14.78	24.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	148.49	5.43	17.58
Fibroblast - skin walker warburg, donor1	11554-120C6	119.26	3.54	26.99
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	96.60	6.12	49.24
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	927.31	16.56	92.38
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	426.98	8.67	26.18
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	249.83	4.94	14.57
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	309.43	5.62	13.29
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	79.62	0.77	16.84
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.27	1.28	12.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	50.78	0.57	17.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	18.48	1.10	19.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.19	1.14	24.89
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.20	1.19	25.36
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	19.03	0.53	27.49
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.94	1.30	23.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.44	0.88	10.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	84.79	1.27	13.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	72.28	1.23	20.56
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	67.16	1.61	11.82
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	133.06	1.98	25.77
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	77.38	1.52	18.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	89.45	0.81	12.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	174.10	2.74	25.78
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	99.53	2.12	24.04
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	129.18	1.09	18.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	257.07	3.84	56.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	120.81	3.50	33.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	180.08	3.80	33.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	172.60	3.02	38.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	152.00	4.24	37.15
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	263.18	4.52	31.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	186.99	5.62	50.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	195.88	6.15	41.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	110.76	3.21	31.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	270.06	4.74	38.69
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	282.99	7.96	35.94
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	128.94	5.36	55.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	93.96	4.27	32.51
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	141.08	6.17	42.36
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	117.93	4.41	50.70
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	86.09	3.69	43.05
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	187.38	7.13	45.39
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	126.36	4.49	41.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	103.85	3.79	42.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	117.37	6.01	45.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	118.59	4.56	42.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	104.85	4.18	38.37
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	186.40	6.37	49.18
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	139.15	5.61	39.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	111.20	8.15	34.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	137.18	8.29	27.54
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	123.63	8.87	29.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	133.94	9.07	36.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	153.43	10.84	49.34
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	130.89	7.56	43.14
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	129.18	9.21	44.52
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	130.91	2.98	51.57
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	170.30	11.61	51.18
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	187.84	10.49	56.29
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	262.04	10.17	100.39
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	32.84	0.60	3.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.87	0.62	8.01
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.03	1.43	10.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	61.96	1.56	12.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.38	1.41	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	0.00	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	86.26	0.39	14.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	195.75	3.21	17.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	1.74	27.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	120.10	1.63	15.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	139.19	2.06	18.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	0.00	29.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	155.76	1.68	10.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	166.04	0.65	18.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	143.44	1.68	28.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	155.86	1.27	16.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	166.09	1.70	21.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	198.37	0.00	31.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	144.89	1.15	26.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	195.94	0.89	25.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	240.57	3.39	37.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	215.80	4.14	32.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	150.96	2.07	25.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	374.06	0.00	57.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	280.62	5.00	21.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	266.32	2.61	28.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	389.93	5.35	52.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	244.65	1.93	36.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	209.17	1.71	32.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	409.99	4.97	49.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	181.19	2.36	25.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	311.40	1.81	35.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	274.68	5.60	52.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	259.25	2.39	29.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	334.00	2.96	28.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	256.16	3.54	38.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	283.55	2.33	37.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	323.89	3.95	31.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	120.37	0.85	24.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	235.78	5.37	35.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	273.19	2.43	23.29
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	116.41	3.42	36.52
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	214.15	7.07	63.20
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	137.18	3.37	24.74
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	235.65	21.25	33.30
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	443.22	28.41	55.98
Hep-2 cells mock treated, biol_rep1	11898-125E8	68.46	0.81	24.37
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.69	1.18	27.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	76.44	1.14	24.12
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	71.38	0.87	30.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.71	1.07	29.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	76.43	1.51	26.48
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	78.33	1.12	30.39
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	70.85	1.54	27.45
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	80.73	1.28	30.76
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	298.28	2.24	17.91
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	299.06	13.85	35.49
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	475.89	15.86	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1393.60	22.93	40.56
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	969.89	21.07	58.85
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	456.33	15.04	29.02
Hepatocyte, donor1	11523-119I2	1320.77	12.11	93.22
Hepatocyte, donor2	11603-120I1	749.83	12.93	54.94
Hepatocyte, donor3	11684-122I1	766.92	9.82	79.15
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	798.23	3.67	26.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	230.64	8.37	32.93
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	3.18	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	6.68	33.38
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	1.38	13.84
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	5.01	15.02
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	11.87	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	5.13	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	9.14	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	6.50	14.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	65.02	3.33	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	10.89	25.41
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	59.56	3.97	11.91
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	6.65	15.52
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	0.00	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.17	5.04	20.16
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	58.77	1.55	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	68.48	3.23	17.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	53.13	1.61	19.32
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	47.79
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	61.12	3.26	17.93
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	55.83	2.94	18.05
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	53.04	3.21	16.88
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	45.24	2.77	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	54.76	6.61	14.16
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	43.54	2.72	11.79
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	58.11	4.30	17.22
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	53.36	2.54	12.70
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.10	4.46	11.48
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	0.00	20.05
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	64.27	0.71	19.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	29.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	52.78	3.09	19.75
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	0.00	17.56
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	6.29	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.11	4.17	21.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	8.85	22.13
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	68.08	6.48	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	90.68	6.98	27.03
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	0.00	24.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	59.24	13.94	27.88
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	84.28	4.27	25.60
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	80.36	2.77	12.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	8.55	8.55
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	67.19	2.76	23.01
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	69.58	3.03	30.25
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	86.92	6.21	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	79.30	5.29	37.01
Keratinocyte - epidermal, donor1	11272-116H3	459.57	7.59	19.75
Keratinocyte - epidermal, donor2	11349-117G8	339.08	7.61	29.28
Keratinocyte - epidermal, donor3	11421-118F8	178.71	3.88	19.40
Keratinocyte - oral, donor1	11251-116E9	362.92	5.68	37.35
Keratocytes, donor1	11527-119I6	224.87	6.53	34.38
Keratocytes, donor2	11607-120I5	367.95	3.52	31.64
Keratocytes, donor3	11688-122I5	298.57	6.72	75.09
Krukenberg tumor cell line:HSKTC	10687-109F3	230.78	15.39	6.59
Lens Epithelial Cells, donor1	11529-119I8	212.51	5.39	30.20
Lens Epithelial Cells, donor2	11609-120I7	278.30	12.34	62.51
Lens Epithelial Cells, donor3	11690-122I7	396.17	17.05	50.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	194.70	3.20	28.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	135.63	8.93	25.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	208.26	2.68	27.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	177.98	1.08	23.12
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	124.49	7.25	25.53
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	235.90	2.48	27.17
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	126.40	3.28	20.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	160.29	9.10	33.37
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	213.52	2.25	24.49
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	149.51	1.98	25.31
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	143.86	9.50	29.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	250.14	2.22	28.33
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	163.76	4.53	21.60
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	154.56	10.73	26.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	225.66	2.88	27.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	158.91	1.54	25.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	148.70	10.29	31.17
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	263.14	2.20	25.98
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	181.67	1.97	24.68
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	156.39	10.54	25.77
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	292.99	4.23	25.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	168.77	3.39	19.40
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	130.07	8.08	22.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	250.23	1.51	26.34
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	150.86	2.07	21.77
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	136.10	10.89	22.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	240.90	1.95	24.66
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	171.28	3.44	19.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	134.34	10.35	26.34
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	228.71	2.54	31.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	165.24	4.36	20.35
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	128.35	9.92	21.50
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	240.60	3.10	29.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	181.03	5.18	27.77
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	133.18	10.62	25.45
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	248.04	2.61	25.44
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	162.75	1.93	17.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	143.34	10.04	20.09
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	238.50	3.36	23.79
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	140.09	3.20	20.62
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	169.19	11.15	25.69
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	272.47	3.27	28.48
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	164.73	3.94	25.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	139.16	10.78	24.83
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	276.39	3.30	30.84
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	175.85	2.85	27.60
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	139.08	11.27	34.06
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	196.62	4.18	26.26
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	253.79	2.27	63.45
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	239.35	2.30	81.32
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	235.29	2.97	59.38
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	342.73	5.08	62.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	340.41	3.52	86.51
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	339.03	14.01	88.73
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	323.59	3.09	71.11
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	330.67	7.14	73.75
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	397.42	6.33	96.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	318.75	5.82	62.24
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	294.41	5.40	69.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	382.21	4.74	93.21
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	332.25	3.59	77.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	301.34	4.23	77.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	273.19	3.33	65.30
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	274.05	2.04	56.03
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	278.81	4.80	69.10
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	291.92	3.59	72.55
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	236.22	3.68	52.15
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	290.29	6.52	70.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	290.92	3.75	57.89
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	297.64	7.01	70.35
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	251.40	5.15	55.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	307.14	4.64	66.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	278.90	6.58	62.18
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	271.10	4.43	61.41
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	269.36	3.89	55.85
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	271.79	2.95	49.79
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	242.92	4.61	50.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	280.52	4.99	59.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	254.19	1.13	37.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	274.04	3.28	49.23
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	265.71	4.97	51.51
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	310.24	4.31	37.34
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	318.93	2.24	68.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	252.31	1.86	59.08
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	278.26	3.88	50.40
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	252.61	5.14	49.67
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	320.85	4.33	60.31
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	274.51	2.41	44.04
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	258.09	4.27	74.65
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	251.60	1.72	61.87
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	273.20	3.22	46.70
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	272.04	4.04	66.66
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	264.10	2.59	65.93
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	240.73	0.00	45.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	264.44	4.23	61.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	266.10	3.20	58.02
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	257.31	2.18	41.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	272.88	6.13	66.69
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	283.14	2.96	63.14
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	251.23	3.76	36.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	256.94	6.54	63.86
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	252.35	2.70	48.22
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	268.49	5.16	29.26
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	267.21	5.34	69.92
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	261.99	2.74	53.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	244.10	2.64	42.22
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	250.12	5.19	64.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	217.47	4.81	50.76
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	261.10	2.24	46.96
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	264.10	4.86	68.45
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	256.11	2.70	58.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	262.80	2.53	45.57
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	250.40	3.84	52.87
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	272.32	3.98	60.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	284.97	5.47	41.93
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	240.02	1.38	15.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	259.15	4.94	55.86
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	268.54	4.13	51.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	264.23	3.02	32.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	267.46	4.12	66.23
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	213.77	2.13	37.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	254.00	6.32	24.71
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	221.63	4.63	53.48
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	254.65	4.95	37.49
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	257.64	3.97	25.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	238.38	2.91	48.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	240.39	3.92	40.72
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	275.58	1.67	27.56
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	248.12	1.39	54.83
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	244.20	2.68	45.50
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	301.00	7.48	24.59
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	214.57	2.42	49.30
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	193.65	1.84	32.12
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	243.62	2.67	18.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	231.94	1.71	46.16
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	218.57	3.07	42.18
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	238.57	4.92	31.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	190.65	3.56	43.21
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	228.24	3.38	62.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	226.12	3.32	32.49
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	280.61	6.24	62.36
Macrophage - monocyte derived, donor1	11232-116C8	1271.08	29.40	98.92
Macrophage - monocyte derived, donor2	11313-117C8	395.46	5.87	54.69
Macrophage - monocyte derived, donor3	11389-118C3	558.54	10.36	81.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	558.63	11.15	18.05
Mallassez-derived cells, donor2	11929-125I3	243.38	10.77	22.82
Mallassez-derived cells, donor3	11930-125I4	260.74	7.51	16.68
Mammary Epithelial Cell, donor1	11273-116H4	167.70	1.40	33.28
Mammary Epithelial Cell, donor2	11350-117G9	290.71	8.69	24.61
Mammary Epithelial Cell, donor3	11422-118F9	399.58	10.73	42.90
Mast cell - stimulated, donor1	11487-119E2	84.06	15.59	3.39
Mast cell, donor1	11563-120D6	61.53	14.49	12.22
Mast cell, donor2	11565-120D8	123.33	12.18	23.18
Mast cell, donor3	11566-120D9	166.14	12.83	26.56
Mast cell, donor4	11567-120E1	122.86	7.98	20.92
Mast cell, expanded and stimulated, donor5	11940-126A5	100.14	18.30	12.64
Mast cell, expanded and stimulated, donor8	11942-126A7	84.05	20.43	11.09
Mast cell, expanded, donor5	11939-126A4	147.65	25.58	21.68
Mast cell, expanded, donor8	11941-126A6	101.42	27.62	18.41
Melanocyte - dark, donor1	11502-119F8	211.83	4.18	43.08
Melanocyte - dark, donor2	11582-120F7	774.53	20.42	41.88
Melanocyte - dark, donor3	11663-122F7	159.73	20.36	36.29
Melanocyte - light, donor1	11274-116H5	163.85	11.05	39.02
Melanocyte - light, donor2	11351-117H1	232.72	9.55	73.02
Melanocyte - light, donor3	11423-118G1	276.64	6.94	34.69
Melanocyte, donor1 (MC+1)	12641-134G4	346.63	9.06	70.28
Melanocyte, donor2 (MC+2)	12739-135I3	192.29	7.53	40.34
Melanocyte, donor3 (MC+3)	12837-137B2	254.46	14.20	79.55
Meningeal Cells, donor1	11493-119E8	471.92	19.11	14.27
Meningeal Cells, donor2	11573-120E7	333.19	8.80	8.80
Meningeal Cells, donor3	11654-122E7	342.71	14.18	29.50
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	168.53	7.41	33.65
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	233.97	9.56	44.18
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5029.31	148.50	132.73
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	871.24	14.39	39.24
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	592.74	17.22	41.62
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	212.83	9.32	44.68
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	142.75	3.52	33.68
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	254.91	7.47	21.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	136.62	3.65	14.61
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	214.63	7.57	24.76
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	385.33	12.74	29.50
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1316.65	31.60	48.70
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	526.82	8.55	52.50
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	735.32	23.44	75.67
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	551.19	18.68	60.72
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	235.67	9.61	27.54
Mesenchymal stem cells - adipose, donor0	11217-116B2	415.76	12.76	37.57
Mesenchymal stem cells - hepatic, donor0	11218-116B3	390.59	5.94	44.72
Mesenchymal stem cells - umbilical, donor0	11214-116A8	236.58	17.42	31.20
Mesothelial Cells, donor1	11247-116E5	405.45	26.25	38.19
Mesothelial Cells, donor2	12156-128G5	306.29	32.53	30.53
Mesothelial Cells, donor3	11402-118D7	268.10	6.87	23.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	700.82	25.66	33.76
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1322.25	38.42	79.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	830.08	12.66	65.96
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	708.70	17.29	34.57
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1195.46	35.02	84.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	779.74	17.63	61.82
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	667.02	25.48	39.37
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1541.36	34.29	96.60
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	939.80	16.29	40.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	720.25	58.40	38.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1336.35	34.34	89.01
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	931.30	13.86	61.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	410.47	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1682.27	34.51	99.11
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	987.46	15.96	71.43
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	623.74	23.69	46.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1651.74	48.81	83.40
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	472.38	6.45	23.94
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1335.89	45.90	77.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	380.61	11.74	21.80
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	305.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1545.56	49.43	91.33
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	682.82	10.70	48.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	543.48	14.93	38.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1326.68	40.75	79.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	686.76	10.52	50.90
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1077.84	35.87	74.60
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1412.95	41.84	111.35
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	623.75	8.89	40.46
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	371.47	10.32	20.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1138.89	33.07	92.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	438.01	8.62	24.84
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	603.15	24.85	36.45
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1043.14	35.88	85.07
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	695.80	10.88	38.82
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	500.46	21.81	29.44
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1439.74	49.02	126.87
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	723.61	6.80	53.63
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	426.45	31.54	24.68
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1615.36	50.06	129.15
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	1482.09	80.84	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	303.74	14.27	20.39
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1502.07	44.23	98.09
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	277.02	13.24	17.66
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	474.53	21.77	32.02
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1395.54	41.40	96.44
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	303.41	8.35	17.40
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	408.83	26.52	39.78
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1358.96	41.71	95.73
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	395.17	11.82	28.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	545.43	23.79	27.34
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1221.80	31.98	96.79
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	393.60	12.88	37.82
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	354.31	9.32	33.80
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1019.63	34.09	78.43
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	495.86	9.60	42.16
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	252.66	36.09	28.88
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	808.11	21.24	65.57
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	492.29	14.23	42.68
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	484.05	17.55	33.85
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	914.79	28.25	72.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	493.75	10.30	25.74
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	312.51	13.34	34.30
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	621.32	21.35	50.44
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	525.02	14.07	56.87
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	495.94	17.23	41.95
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1027.52	26.76	77.40
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	500.42	14.15	47.32
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	401.95	16.31	37.16
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	766.23	21.59	68.75
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	644.74	19.42	61.94
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	269.14	18.90	21.51
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	551.30	18.23	61.16
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	568.00	12.97	57.38
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	417.91	14.01	30.91
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	507.12	15.78	63.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1461.55	67.80	165.74
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1942.65	32.08	165.75
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2714.33	55.53	144.57
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1742.03	35.77	170.42
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1832.55	104.97	133.44
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2176.50	32.60	160.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2798.82	43.56	155.47
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1615.63	32.76	136.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1043.24	74.42	75.44
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2143.87	42.73	151.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2329.73	49.83	129.71
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1459.15	34.22	136.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1642.33	126.66	110.09
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	2735.64	42.50	266.61
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3056.08	58.58	193.91
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1385.93	26.56	117.22
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1933.96	136.19	192.03
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4501.43	103.63	373.85
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4617.69	144.15	267.25
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1845.75	30.21	190.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	571.02	5.71	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	972.21	22.84	101.14
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1558.81	23.76	47.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	514.51	12.55	138.04
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	145.20	13.14	31.67
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	117.07	8.88	56.44
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	128.83	21.36	36.71
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	110.19	6.68	30.89
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	70.73	13.12	35.18
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	106.92	14.36	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	150.27	5.44	34.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	1.84	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	141.05	12.14	64.87
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	133.88	7.21	42.30
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	195.64	18.38	54.59
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	151.16	10.51	33.01
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	217.90	6.45	55.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	94.19	14.07	60.90
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	225.10	8.84	64.83
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	187.47	19.60	65.81
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	195.56	11.66	39.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	247.18	12.73	64.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	237.72	9.00	58.83
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	78.43	13.46	46.93
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	177.26	6.67	67.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	192.43	10.58	39.69
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	260.90	12.66	77.36
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	193.08	6.44	81.37
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	255.47	16.39	120.83
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	95.88	5.52	61.39
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	7.59	32.87
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	184.91	9.36	36.09
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	190.10	7.20	79.60
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	164.72	9.97	55.78
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	296.18	20.17	118.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	0.00	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	244.25	16.66	58.65
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	156.45	8.12	26.60
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	151.58	3.57	55.16
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	311.10	10.22	78.01
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	143.02	13.24	85.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	199.44	7.82	70.72
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	195.23	14.38	36.17
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	114.43	7.69	24.42
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	192.26	7.06	68.79
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	373.64	12.63	122.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	299.61	16.87	93.75
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	172.65	3.45	54.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	284.60	27.52	106.16
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	137.03	4.42	33.82
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	176.87	8.13	79.96
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	0.00	45.99
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	257.90	20.12	89.62
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	111.42	6.29	57.28
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	191.88	22.70	72.03
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	154.27	9.49	68.83
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	82.76	3.40	56.68
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	10.12	35.41
Myoblast, donor1	11241-116D8	318.15	7.83	29.44
Myoblast, donor2	11322-117D8	322.59	8.44	45.26
Myoblast, donor3	11398-118D3	298.49	12.11	31.95
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.88	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	142.69	21.53	3.69
Natural Killer Cells, donor2	11311-117C6	15.68	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	246.63	20.98	10.31
Neural stem cells, donor1	11275-116H6	1182.09	8.35	18.87
Neural stem cells, donor2	11352-117H2	132.87	7.70	17.33
Neurons, donor1	11494-119E9	165.00	0.00	23.90
Neurons, donor2	11574-120E8	122.63	2.20	28.40
Neurons, donor3	11655-122E8	150.46	5.76	52.62
Neutrophils, donor1	11233-116C9	248.71	10.21	20.42
Neutrophils, donor2	11314-117C9	139.15	5.80	23.19
Neutrophils, donor3	11390-118C4	169.20	9.16	14.05
Nucleus Pulposus Cell, donor1	11252-116F1	319.28	8.91	59.49
Nucleus Pulposus Cell, donor2	11409-118E5	714.05	23.12	54.05
Nucleus Pulposus Cell, donor3	11462-119B4	816.65	11.03	34.50
Olfactory epithelial cells, donor1	11933-125I7	150.87	3.72	66.76
Olfactory epithelial cells, donor2	11934-125I8	168.34	4.92	78.45
Olfactory epithelial cells, donor3	11935-125I9	180.70	4.65	77.86
Olfactory epithelial cells, donor4	11936-126A1	297.55	6.04	105.58
Oligodendrocyte - precursors, donor1	11496-119F2	134.21	4.21	32.50
Osteoblast - differentiated, donor1	11276-116H7	624.68	25.52	84.44
Osteoblast - differentiated, donor2	11353-117H3	499.54	34.29	89.16
Osteoblast - differentiated, donor3	11425-118G3	722.51	18.62	84.42
Osteoblast, donor1	11277-116H8	142.47	5.67	44.36
Osteoblast, donor2	11354-117H4	84.98	7.02	21.07
Osteoblast, donor3	11426-118G4	157.47	7.11	34.84
Pancreatic stromal cells, donor1	11249-116E7	147.08	4.97	39.59
Pericytes, donor1	11491-119E6	661.70	17.36	34.16
Pericytes, donor2	11571-120E5	597.61	21.05	27.62
Pericytes, donor3	11652-122E5	619.71	20.75	44.96
Perineurial Cells, donor1	11499-119F5	271.14	7.23	53.12
Perineurial Cells, donor2	11579-120F4	831.78	21.71	34.78
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	792.71	54.82	30.60
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1178.52	91.58	48.48
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	792.67	43.22	31.45
Placental Epithelial Cells, donor1	11278-116H9	199.46	2.63	37.07
Placental Epithelial Cells, donor2	11355-117H5	369.26	15.52	65.42
Placental Epithelial Cells, donor3	11427-118G5	429.56	11.39	56.35
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	556.32	28.80	118.67
Preadipocyte - breast, donor1	11467-119B9	611.54	26.83	47.46
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	279.72	13.18	27.15
Preadipocyte - breast, donor2	11328-117E5	498.48	19.36	65.97
Preadipocyte - omental, donor1	11468-119C1	725.56	24.83	76.62
Preadipocyte - omental, donor2	11329-117E6	453.93	17.46	46.70
Preadipocyte - omental, donor3	11403-118D8	500.80	22.78	80.51
Preadipocyte - perirenal, donor1	11469-119C2	1014.78	27.56	48.23
Preadipocyte - subcutaneous, donor1	11279-116I1	79.24	2.76	18.43
Preadipocyte - subcutaneous, donor2	11356-117H6	164.15	7.79	22.49
Preadipocyte - subcutaneous, donor3	11428-118G6	259.85	13.11	54.83
Preadipocyte - visceral, donor1	11280-116I2	187.04	5.22	21.52
Preadipocyte - visceral, donor2	11357-117H7	314.30	8.28	22.09
Preadipocyte - visceral, donor3	11429-118G7	153.91	13.27	26.44
Prostate Epithelial Cells (polarized), donor1	11253-116F2	520.14	2.72	20.06
Prostate Epithelial Cells, donor2	11331-117E8	190.80	5.42	13.27
Prostate Epithelial Cells, donor3	11404-118D9	165.40	3.37	25.96
Prostate Stromal Cells, donor1	11254-116F3	187.82	4.33	33.60
Prostate Stromal Cells, donor2	11332-117E9	413.82	7.53	31.56
Prostate Stromal Cells, donor3	11405-118E1	362.36	4.59	39.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	320.45	9.85	27.01
Renal Cortical Epithelial Cells, donor2	11596-120H3	264.98	6.45	39.09
Renal Epithelial Cells, donor1	11517-119H5	469.70	12.68	42.10
Renal Epithelial Cells, donor2	11597-120H4	418.26	9.96	54.77
Renal Epithelial Cells, donor3	11678-122H4	377.62	10.80	43.93
Renal Glomerular Endothelial Cells, donor1	11514-119H2	374.47	9.53	10.21
Renal Glomerular Endothelial Cells, donor2	11594-120H1	435.96	8.62	15.90
Renal Glomerular Endothelial Cells, donor3	11675-122H1	327.24	14.43	24.64
Renal Glomerular Endothelial Cells, donor4	11783-124B1	395.94	8.65	51.24
Renal Mesangial Cells, donor1	11518-119H6	437.76	9.24	28.39
Renal Mesangial Cells, donor2	11598-120H5	453.31	15.05	43.26
Renal Mesangial Cells, donor3	11679-122H5	508.77	11.10	46.61
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	270.84	4.29	22.55
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	179.64	5.48	22.35
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	373.35	9.06	31.43
Retinal Pigment Epithelial Cells, donor0	11215-116A9	223.50	5.70	33.45
Retinal Pigment Epithelial Cells, donor1	11528-119I7	388.56	11.65	25.87
Retinal Pigment Epithelial Cells, donor2	11608-120I6	188.33	13.38	23.67
Retinal Pigment Epithelial Cells, donor3	11689-122I6	525.40	7.78	33.12
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	647.60	9.89	74.84
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	109.89	14.29	41.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	72.65	14.86	58.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	54.53	9.86	36.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	60.20	9.36	13.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	72.59	8.24	46.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.19	12.16	34.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	56.07	6.57	19.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	90.79	6.53	46.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	87.60	8.55	40.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	62.98	5.34	23.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	56.58	8.02	38.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	69.71	7.88	46.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	78.47	6.60	26.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	82.95	8.80	43.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	101.56	9.29	49.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	68.44	3.44	25.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	77.05	7.64	37.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	75.35	11.27	26.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	64.50	6.24	20.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	71.25	6.81	40.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	97.01	7.64	37.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	69.31	7.69	25.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.80	10.37	31.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	80.66	7.86	34.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.63	6.02	26.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	75.79	6.87	38.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	88.92	8.60	49.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	84.21	4.01	26.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	75.99	9.72	39.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	91.20	8.65	46.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	77.34	8.29	31.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	68.58	10.18	33.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	77.29	8.56	39.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	76.44	7.67	28.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	65.05	8.34	34.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	87.53	10.22	48.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	70.67	6.02	27.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	73.93	7.13	38.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	78.97	8.54	39.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	69.71	7.33	27.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	71.76	7.99	46.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	77.30	6.40	33.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	96.23	10.09	27.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	85.72	8.81	58.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	97.14	9.67	43.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	107.45	11.49	32.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	108.30	16.07	65.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	97.61	13.30	52.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	111.37	11.75	39.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	89.22	12.81	45.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	132.64	23.73	78.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	124.18	14.47	40.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	202.89	26.01	103.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	166.54	23.66	82.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	139.33	21.73	41.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	155.60	18.57	61.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	131.01	12.02	50.48
Schwann Cells, donor1	11498-119F4	434.07	18.24	28.40
Schwann Cells, donor2	11578-120F3	193.94	6.80	37.43
Schwann Cells, donor3	11659-122F3	321.39	14.90	34.40
Sebocyte, donor1	11220-116B5	380.15	4.93	15.34
Sebocyte, donor2	11301-117B5	236.67	3.22	9.65
Sebocyte, donor3	11378-118B1	434.07	9.89	36.07
Sertoli Cells, donor1	11255-116F4	276.65	9.94	49.70
Sertoli Cells, donor2	11333-117F1	485.79	19.77	87.56
Skeletal Muscle Cells, donor1	11281-116I3	80.59	3.43	29.91
Skeletal Muscle Cells, donor2	11358-117H8	139.51	5.78	42.65
Skeletal Muscle Cells, donor3	11430-118G8	139.62	6.69	18.39
Skeletal Muscle Cells, donor4	11451-119A2	291.41	6.44	19.48
Skeletal Muscle Cells, donor5	11455-119A6	318.25	7.58	18.73
Skeletal Muscle Cells, donor6	11459-119B1	183.61	7.23	13.24
Skeletal Muscle Satellite Cells, donor1	11240-116D7	398.68	13.10	33.77
Skeletal Muscle Satellite Cells, donor2	11321-117D7	357.58	10.13	35.10
Skeletal Muscle Satellite Cells, donor3	11397-118D2	260.23	5.85	20.14
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	81.98	4.80	23.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	105.67	5.79	36.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	103.47	4.54	22.43
Skin - palm, donor1	10286-104F7	295.47	8.06	37.61
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	274.04	3.89	17.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	121.87	3.27	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	286.01	6.23	19.08
Small Airway Epithelial Cells, donor1	11256-116F5	363.64	6.39	14.46
Small Airway Epithelial Cells, donor2	11334-117F2	218.16	3.52	15.61
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	319.92	6.77	8.67
Small Airway Epithelial Cells, donor3	11406-118E2	238.87	3.15	19.86
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	85.79	2.47	12.03
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	702.57	23.79	46.47
Smooth Muscle Cells - Aortic, donor0	11210-116A4	130.50	4.70	24.69
Smooth Muscle Cells - Aortic, donor1	11283-116I5	369.94	8.84	52.37
Smooth Muscle Cells - Aortic, donor2	11360-117I1	339.83	6.69	34.26
Smooth Muscle Cells - Aortic, donor3	11432-118H1	214.77	0.77	19.31
Smooth Muscle Cells - Bladder, donor1	11519-119H7	353.27	14.01	43.03
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	249.92	6.52	44.18
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	531.53	13.30	74.03
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	143.01	3.58	15.11
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	255.91	12.05	20.84
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	425.27	10.34	25.10
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	407.45	12.39	33.46
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	510.64	10.57	27.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	726.38	17.96	42.01
Smooth Muscle Cells - Carotid, donor1	11285-116I7	323.79	10.10	76.53
Smooth Muscle Cells - Carotid, donor2	11362-117I3	159.14	0.00	36.72
Smooth Muscle Cells - Carotid, donor3	11434-118H3	277.52	7.15	26.70
Smooth Muscle Cells - Colonic, donor1	11239-116D6	135.82	7.23	22.42
Smooth Muscle Cells - Colonic, donor2	11320-117D6	258.93	4.74	27.55
Smooth Muscle Cells - Colonic, donor3	11396-118D1	244.97	6.40	26.03
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	311.83	7.58	40.84
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	293.18	10.78	37.73
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	238.49	6.87	21.22
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	351.30	9.90	30.38
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	342.54	5.18	37.62
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	589.25	10.37	31.90
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	617.58	18.43	68.27
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	306.74	11.47	28.98
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	145.97	2.91	17.22
Smooth Muscle Cells - Prostate, donor1	11257-116F6	300.01	5.99	15.85
Smooth Muscle Cells - Prostate, donor2	11335-117F3	301.28	9.64	39.82
Smooth Muscle Cells - Prostate, donor3	11465-119B7	578.35	12.18	44.39
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	364.27	11.01	60.91
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	552.12	16.50	111.77
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	206.75	5.17	10.34
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	177.19	4.65	46.04
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	673.51	21.21	49.48
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	382.65	9.09	36.67
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	554.30	15.34	24.78
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	238.92	5.91	25.91
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	661.96	14.01	52.32
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	192.56	5.76	42.17
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	305.95	5.35	38.75
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	223.20	9.40	27.64
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	197.32	7.97	28.37
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	276.92	10.47	45.58
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	457.61	17.14	51.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	171.51	5.63	41.10
Smooth Muscle Cells - Uterine, donor1	11258-116F7	337.83	10.61	30.49
Smooth Muscle Cells - Uterine, donor3	11466-119B8	226.46	5.85	27.50
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	253.45	7.00	87.27
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	137.52	2.64	32.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	258.87	5.21	56.54
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	275.61	4.31	49.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	203.84	3.41	28.67
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	96.50	6.70	29.15
Smooth muscle cells - airway, control, donor1	11966-126D4	206.46	6.09	69.07
Smooth muscle cells - airway, control, donor2	11967-126D5	319.85	7.19	101.43
Smooth muscle cells - airway, control, donor3	11968-126D6	349.03	9.61	105.76
Smooth muscle cells - airway, control, donor4	11969-126D7	277.31	5.04	83.88
Synoviocyte, donor1	11291-117A4	267.13	5.89	49.99
Synoviocyte, donor2	11368-117I9	763.53	26.65	147.17
Synoviocyte, donor3	11440-118H9	601.64	17.43	65.24
Trabecular Meshwork Cells, donor1	11532-120A2	256.21	10.36	29.30
Trabecular Meshwork Cells, donor2	11612-122A1	331.00	7.93	37.66
Trabecular Meshwork Cells, donor3	11693-123A1	261.42	7.64	54.18
Tracheal Epithelial Cells, donor1	11292-117A5	188.53	3.58	19.64
Tracheal Epithelial Cells, donor2	11369-118A1	269.82	6.57	38.66
Tracheal Epithelial Cells, donor3	11441-118I1	259.42	2.29	18.90
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	657.32	7.87	74.43
Urethra, donor2	10319-105A4	480.18	19.78	57.55
Urothelial Cells, donor1	11520-119H8	258.22	8.24	19.13
Urothelial Cells, donor2	11600-120H7	192.67	2.00	28.84
Urothelial Cells, donor3	11681-122H7	222.10	4.35	36.67
Urothelial cells, donor0	11216-116B1	149.79	3.79	28.98
Whole blood (ribopure), donor090309, donation1	12179-129A1	801.69	79.19	18.69
Whole blood (ribopure), donor090309, donation2	12180-129A2	783.43	70.05	15.73
Whole blood (ribopure), donor090309, donation3	12181-129A3	561.31	46.55	39.70
Whole blood (ribopure), donor090325, donation1	12176-128I7	663.88	45.80	19.63
Whole blood (ribopure), donor090325, donation2	12177-128I8	947.07	59.85	30.79
Whole blood (ribopure), donor090612, donation1	12182-129A4	765.31	59.35	19.78
Whole blood (ribopure), donor090612, donation2	12183-129A5	868.23	67.00	19.27
Whole blood (ribopure), donor090612, donation3	12184-129A6	557.78	51.12	27.39
Wilms' tumor cell line:G-401	10809-111A8	29.11	0.37	13.45
Wilms' tumor cell line:HFWT	10597-108E3	105.60	0.88	12.32
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	255.58	5.03	39.38
achilles tendon, donor2	10292-104G4	622.03	28.93	43.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3.25	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	4.04	0.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	5.44	0.27	3.81
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.87	4.22	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	274.08	45.26	21.57
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	30.22	5.17	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	134.39	17.18	13.22
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	104.95	10.21	20.83
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	658.17	22.91	17.86
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.30	1.10	4.05
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	249.63	27.30	19.50
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.29	3.25	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	324.92	28.48	18.64
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	253.67	21.33	13.74
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	304.42	18.59	30.67
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	484.04	65.80	49.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	232.98	9.21	24.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	318.75	11.52	37.98
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	542.59	12.44	24.87
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	352.63	9.63	23.11
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	260.83	19.16	21.16
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	101.73	8.67	13.68
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	42.74	0.00	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	106.59	29.38	25.61
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	69.35	29.22	8.72
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	59.98	43.11	13.12
adenocarcinoma cell line:IM95m	10796-110I4	222.78	3.53	77.95
adipose tissue, adult, pool1	10010-101C1	1161.38	16.60	63.91
adipose, donor1	10184-103D4	10.56	0.00	10.56
adipose, donor2	10185-103D5	26.76	0.81	52.31
adipose, donor3	10186-103D6	32.67	1.09	39.75
adipose, donor4	10187-103D7	31.20	0.00	25.14
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	38.82	4.26	17.68
adrenal gland, adult, pool1	10081-102A9	592.94	10.91	149.14
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.27	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	285.48	8.58	42.88
amniotic membrane cells, donor1	12235-129G3	120.10	1.39	67.24
amniotic membrane cells, donor2	12236-129G4	202.86	6.42	75.40
amniotic membrane cells, donor3	12237-129G5	114.89	1.18	28.87
amygdala - adult, donor10196	10167-103B5	2695.32	11.86	14.23
amygdala, adult, donor10252	10151-102I7	2873.42	7.30	16.42
amygdala, newborn, donor10223	10360-105E9	1292.37	2.58	18.08
anaplastic carcinoma cell line:8305C	10428-106D5	336.66	4.46	35.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	50.52	2.65	13.46
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	61.80	1.34	26.05
aorta, adult, pool1	10052-101G7	887.11	13.14	195.74
appendix, adult	10189-103D9	1003.67	6.99	42.69
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	111.78	1.72	52.62
artery, adult	10190-103E1	1190.21	8.15	50.27
astrocytoma cell line:TM-31	10425-106D2	202.67	7.39	48.39
b cell line:RPMI1788	10427-106D4	16.06	0.59	2.68
basal cell carcinoma cell line:TE 354.T	10702-109G9	346.53	10.27	53.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	138.53	3.18	18.46
bile duct carcinoma cell line:TFK-1	10496-107C1	91.05	0.00	14.39
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	461.37	17.90	50.33
bladder, adult, pool1	10011-101C2	830.89	6.52	79.31
blood, adult, pool1	10053-101G8	713.11	39.86	62.01
bone marrow stromal cell line:StromaNKtert	10686-109F2	444.44	17.98	17.13
bone marrow, adult	10192-103E3	4852.00	32.39	44.54
brain, adult, donor1	10084-102B3	4834.22	13.33	35.88
brain, adult, pool1	10012-101C3	2803.00	10.36	19.04
brain, fetal, pool1	10085-102B4	1439.88	18.70	26.71
breast carcinoma cell line:MCF7	10482-107A5	178.07	4.29	43.94
breast carcinoma cell line:MDA-MB-453	10419-106C5	14.85	0.00	7.86
breast, adult, donor1	10080-102A8	1043.00	10.10	133.85
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	204.28	2.67	17.28
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	170.69	5.88	45.15
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	60.32	2.53	20.72
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	110.63	1.45	27.60
carcinoid cell line:NCI-H1770	10703-109H1	36.67	0.00	12.69
carcinoid cell line:NCI-H727	10735-110B6	629.70	17.50	74.05
carcinoid cell line:SK-PN-DW	10719-109I8	70.03	1.27	10.77
carcinosarcoma cell line:JHUCS-1	10642-109A3	55.63	1.06	16.50
caudate nucleus - adult, donor10196	10177-103C6	2778.14	4.61	29.93
caudate nucleus, adult, donor10252	10164-103B2	1770.65	6.19	21.59
caudate nucleus, adult, donor10258	10379-105H1	3269.75	20.63	24.45
caudate nucleus, newborn, donor10223	10354-105E3	1616.92	5.49	19.78
cerebellum - adult, donor10196	10173-103C2	2117.95	8.74	40.79
cerebellum, adult, donor10252	10166-103B4	1723.67	1.92	19.64
cerebellum, adult, pool1	10083-102B2	1992.06	6.21	26.91
cerebellum, newborn, donor10223	10357-105E6	4595.64	14.95	30.72
cerebral meninges, adult	10188-103D8	2684.53	7.82	51.69
cerebrospinal fluid, donor2	10294-104G6	583.98	8.04	19.00
cervical cancer cell line:D98-AH2	10552-107I3	122.65	1.29	55.93
cervical cancer cell line:ME-180	10553-107I4	172.51	1.82	33.47
cervix, adult, pool1	10013-101C4	749.21	12.18	122.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	248.72	15.88	30.93
chondrosarcoma cell line:SW 1353	10700-109G7	41.80	2.61	5.23
choriocarcinoma cell line:BeWo	10423-106C9	55.05	1.74	11.56
choriocarcinoma cell line:SCH	10785-110H2	76.88	0.62	6.90
choriocarcinoma cell line:T3M-3	10618-108G6	25.14	0.00	5.93
chorionic membrane cells, donor1	12238-129G6	143.31	1.99	33.05
chorionic membrane cells, donor2	12239-129G7	267.37	3.58	44.74
chorionic membrane cells, donor3	12240-129G8	243.97	3.30	10.44
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1.01	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.99	1.15	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	52.80	14.78	8.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.71	2.57	6.16
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	34.10	1.45	6.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	31.76	1.63	4.68
chronic myelogenous leukemia cell line:K562	10454-106G4	88.34	5.30	12.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	91.22	21.89	21.11
clear cell carcinoma cell line:JHOC-5	10638-108I8	92.58	0.69	48.46
clear cell carcinoma cell line:TEN	10636-108I6	157.02	1.04	20.47
colon carcinoma cell line:CACO-2	10513-107D9	992.82	2.38	24.16
colon carcinoma cell line:COLO-320	10420-106C6	244.01	3.42	43.71
colon, adult, donor1	10082-102B1	687.84	10.71	155.89
colon, adult, pool1	10014-101C5	787.98	16.45	111.16
colon, fetal, donor1	10070-101I7	525.29	6.80	111.86
common myeloid progenitor CMP, donor1	12130-128D6	13.75	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	35.27	1.27	8.50
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.47	1.36	8.15
cord blood derived cell line:COBL-a untreated	10449-106F8	58.80	0.99	6.91
corpus callosum, adult, pool1	10042-101F6	2357.08	13.27	49.86
cruciate ligament, donor2	10295-104G7	622.44	15.40	39.71
diaphragm, fetal, donor1	10069-101I6	656.50	7.22	56.98
diencephalon, adult	10193-103E4	3367.52	33.84	18.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	185.41	2.05	17.18
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	112.18	4.09	21.42
ductus deferens, adult	10196-103E7	767.94	6.48	202.33
duodenum, fetal, donor1, tech_rep1	10071-101I8	650.98	8.64	129.62
duodenum, fetal, donor1, tech_rep2	10071-101I8	767.28	19.13	92.69
dura mater, adult, donor1	10041-101F5	1567.84	45.59	115.95
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	99.04	3.33	18.65
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	154.18	3.30	22.50
embryonic pancreas cell line:1B2C6	10604-108F1	112.84	3.08	6.78
embryonic pancreas cell line:1C3D3	10605-108F2	121.08	2.42	26.03
embryonic pancreas cell line:1C3IKEI	10606-108F3	106.83	5.56	12.97
embryonic pancreas cell line:2C6	10603-108E9	107.70	3.94	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	166.59	2.68	58.32
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	133.75	3.08	38.06
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	160.01	1.45	25.89
epidermoid carcinoma cell line:A431	10426-106D3	333.25	7.00	18.90
epidermoid carcinoma cell line:Ca Ski	10431-106D8	160.58	14.63	31.68
epididymis, adult	10197-103E8	2077.41	20.51	129.77
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	69.01	1.06	28.21
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.17	1.18	5.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	79.81	1.18	22.02
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	74.21	0.79	20.96
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.43	0.56	25.21
esophagus, adult, pool1	10015-101C6	1444.45	8.92	87.60
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	79.15	1.38	27.93
eye - muscle inferior rectus, donor1	10272-104E2	709.88	12.07	16.90
eye - muscle lateral, donor2	10298-104H1	597.59	12.63	27.35
eye - muscle medial, donor2	10299-104H2	482.18	13.39	11.91
eye - muscle superior, donor2	10297-104G9	814.01	6.88	24.08
eye - vitreous humor, donor1	10268-104D7	215.69	8.74	23.32
eye, fetal, donor1	10054-101G9	1134.65	6.10	75.51
fibrosarcoma cell line:HT-1080	10758-110E2	129.76	8.21	26.93
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	79.30	1.66	18.28
frontal lobe, adult, pool1	10040-101F4	2808.06	6.57	14.45
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	231.19	3.30	70.86
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	225.85	11.06	40.32
gall bladder, adult	10198-103E9	1752.56	21.73	199.42
gamma delta positive T cells, donor1	11937-126A2	224.94	6.44	5.91
gamma delta positive T cells, donor2	11938-126A3	481.43	23.90	13.07
gastric adenocarcinoma cell line:MKN1	10614-108G2	150.60	2.75	25.13
gastric adenocarcinoma cell line:MKN45	10612-108F9	185.49	3.67	33.46
gastric cancer cell line:AZ521	10549-107H9	51.65	0.66	14.76
gastric cancer cell line:GSS	10560-108A2	845.67	7.32	227.89
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.86	0.46	22.62
giant cell carcinoma cell line:LU65	10487-107B1	78.37	5.62	13.20
giant cell carcinoma cell line:Lu99B	10433-106E1	84.68	3.22	17.35
glassy cell carcinoma cell line:HOKUG	10688-109F4	134.94	3.74	40.16
glioblastoma cell line:A172, tech_rep1	10444-106F3	111.67	4.75	17.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	111.23	6.04	23.17
glioblastoma cell line:T98G	10485-107A8	133.88	5.85	26.49
glioma cell line:GI-1	10413-106B8	32.51	1.76	8.79
globus pallidus - adult, donor10196	10175-103C4	3091.31	13.85	37.17
globus pallidus, adult, donor10252	10161-103A8	1780.91	10.01	32.71
globus pallidus, adult, donor10258	10367-105F7	988.57	6.85	20.54
globus pallidus, newborn, donor10223	10364-105F4	2956.09	12.26	21.85
granulocyte macrophage progenitor, donor1	12131-128D7	208.01	48.94	12.24
granulocyte macrophage progenitor, donor2	12135-128E2	316.92	32.79	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	449.49	156.80	41.81
granulosa cell tumor cell line:KGN	10624-108H3	172.16	9.60	31.36
hIPS +CCl2, biol_rep1	14383-156B9	92.28	0.46	5.51
hIPS +CCl2, biol_rep2	14384-156C1	96.03	0.91	8.23
hIPS +CCl2, biol_rep3	14385-156C2	55.39	0.64	5.15
hIPS, biol_rep1	14380-156B6	74.74	1.44	8.62
hIPS, biol_rep2	14381-156B7	74.07	4.12	7.54
hIPS, biol_rep3	14382-156B8	2489.42	8.83	19.86
hairy cell leukemia cell line:Mo	10712-109I1	1.44	0.29	0.57
heart - mitral valve, adult	10205-103F7	1470.32	13.45	87.30
heart - pulmonic valve, adult	10206-103F8	729.25	8.89	68.51
heart - tricuspid valve, adult	10207-103F9	945.05	8.33	89.93
heart, adult, diseased post-infarction, donor1	10050-101G5	499.12	4.29	71.01
heart, adult, diseased, donor1	10051-101G6	1043.29	12.77	100.07
heart, adult, pool1	10016-101C7	1361.24	12.88	118.44
heart, fetal, pool1	10046-101G1	221.28	2.77	32.34
hepatic mesenchymal tumor cell line:LI90	10778-110G4	263.17	4.63	42.88
hepatoblastoma cell line:HuH-6	10633-108I3	381.73	2.38	15.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1475.01	10.06	42.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1348.83	9.59	44.79
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1460.83	9.90	38.50
hepatoma cell line:Li-7	10484-107A7	177.95	2.45	42.37
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	45.33	4.02	9.95
hippocampus - adult, donor10196	10169-103B7	2755.71	13.25	18.93
hippocampus, adult, donor10252	10153-102I9	3383.57	12.65	31.64
hippocampus, adult, donor10258	10374-105G5	1599.42	6.97	7.47
hippocampus, newborn, donor10223	10363-105F3	3366.51	9.52	16.21
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	33.57	1.83	17.09
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	52.03	1.57	15.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	50.27	1.02	12.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	15.22	0.00	21.99
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	24.79	0.52	25.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	23.54	2.28	18.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	20.44	1.46	20.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.41	0.00	23.91
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	57.14	0.83	21.27
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	97.80	3.08	27.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	79.55	3.38	40.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	119.17	1.35	38.38
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.92	0.78	12.21
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.55	3.44	12.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	18.33	0.00	11.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.11	0.76	25.77
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.53	0.00	26.16
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	21.99	1.00	25.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	24.11	0.94	31.84
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	1.36	32.28
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	24.43	0.94	46.36
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	65.16	2.12	49.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	67.35	2.03	43.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	59.78	1.79	61.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	41.38	0.74	14.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	45.36	1.14	12.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	39.61	1.63	11.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.59	3.52	28.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	76.02	1.27	27.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	66.58	3.03	42.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	63.09	2.07	40.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.07	1.99	42.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	93.12	3.08	33.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	112.74	3.07	46.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	99.20	0.76	58.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	133.41	2.69	58.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	47.82	1.21	13.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	54.37	1.34	14.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	54.63	1.46	18.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.29	0.31	23.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	31.11	0.66	20.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	52.54	2.74	31.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.49	1.09	26.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	44.13	1.78	26.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	72.80	3.58	31.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	81.12	2.44	26.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	73.54	2.16	38.79
immature langerhans cells, donor1	11904-125F5	1377.57	172.17	88.63
immature langerhans cells, donor2	11905-125F6	2005.68	266.16	179.81
insula, adult, pool1	10039-101F3	3306.21	7.76	17.22
keratoacanthoma cell line:HKA-1	10791-110H8	344.01	9.75	115.10
kidney, adult, pool1	10017-101C8	596.26	9.81	76.80
kidney, fetal, pool1	10045-101F9	162.41	3.40	44.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	269.02	18.66	103.82
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	110.83	2.75	8.62
left atrium, adult, donor1	10079-102A7	895.19	17.98	110.06
left ventricle, adult, donor1	10078-102A6	1062.89	6.57	107.70
leiomyoblastoma cell line:G-402	10721-110A1	37.76	0.82	11.22
leiomyoma cell line:10964C	10569-108B2	580.91	9.70	57.84
leiomyoma cell line:15242A	10570-108B3	268.48	8.70	34.24
leiomyoma cell line:15425	10571-108B4	284.58	8.01	55.12
leiomyosarcoma cell line:Hs 5.T	10722-110A2	412.71	12.70	69.84
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	5.23	10.46
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	130.57	25.74	30.34
liposarcoma cell line:KMLS-1	10782-110G8	184.02	7.03	54.83
liposarcoma cell line:SW 872	10726-110A6	211.03	8.29	50.44
liver, adult, pool1	10018-101C9	912.57	9.24	90.75
liver, fetal, pool1	10086-102B5	277.51	12.23	44.21
locus coeruleus - adult, donor10196	10182-103D2	1994.15	11.23	23.77
locus coeruleus, adult, donor10252	10165-103B3	1875.77	8.12	26.21
locus coeruleus, adult, donor10258	10375-105G6	2234.25	12.98	49.94
locus coeruleus, newborn, donor10223	10362-105F2	3598.39	11.78	34.07
lung adenocarcinoma cell line:A549	10499-107C4	174.79	0.69	23.39
lung adenocarcinoma cell line:PC-14	10408-106B3	180.62	7.58	20.68
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.03	0.79	10.41
lung, adult, pool1	10019-101D1	774.21	15.71	103.24
lung, fetal, donor1	10068-101I5	226.33	13.41	14.56
lung, right lower lobe, adult, donor1	10075-102A3	889.40	19.70	159.00
lymph node, adult, donor1	10077-102A5	1531.80	23.19	77.63
lymphangiectasia cell line:DS-1	10727-110A7	54.79	3.73	31.78
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.15	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	236.16	8.49	11.04
mature adipocyte, donor1	12231-129F8	600.27	10.21	106.56
mature adipocyte, donor2	12232-129F9	735.48	10.17	100.65
mature adipocyte, donor3	12233-129G1	893.73	11.14	120.19
mature adipocyte, donor4	12234-129G2	709.11	7.90	64.23
maxillary sinus tumor cell line:HSQ-89	10414-106B9	177.03	10.48	51.46
medial frontal gyrus - adult, donor10196	10170-103B8	2118.44	2.26	11.28
medial frontal gyrus, adult, donor10252	10150-102I6	1773.96	6.25	10.30
medial frontal gyrus, adult, donor10258	10368-105F8	1909.94	10.17	16.20
medial frontal gyrus, newborn, donor10223	10352-105E1	506.24	2.56	11.94
medial temporal gyrus - adult, donor10196	10183-103D3	2275.10	6.24	16.88
medial temporal gyrus, adult, donor10252	10156-103A3	2166.39	4.46	13.58
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1259.77	3.85	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	315.78	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1123.82	4.67	10.05
medulla oblongata - adult, donor10196	10174-103C3	2254.55	16.22	126.55
medulla oblongata, adult, donor10252	10155-103A2	2054.09	13.93	55.57
medulla oblongata, adult, pool1	10038-101F2	2251.36	12.24	45.30
medulla oblongata, newborn, donor10223	10361-105F1	3498.20	18.75	62.15
medulloblastoma cell line:D283 Med	10838-111E1	27.68	0.89	12.84
medulloblastoma cell line:ONS-76	10759-110E3	139.64	5.87	26.53
melanoma cell line:COLO 679	10514-107E1	179.68	7.62	33.78
melanoma cell line:G-361	10465-106H6	136.55	11.40	43.16
meningioma cell line:HKBMM	10691-109F7	196.64	6.69	33.47
merkel cell carcinoma cell line:MKL-1	10843-111E6	44.06	0.00	17.62
merkel cell carcinoma cell line:MS-1	10844-111E7	6.22	0.00	5.44
mesenchymal precursor cell - adipose, donor1	11747-123G1	223.86	11.05	18.26
mesenchymal precursor cell - adipose, donor2	11748-123G2	140.33	5.64	19.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	306.02	6.63	18.63
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	109.15	13.35	25.43
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	195.65	6.16	35.63
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	487.94	17.35	62.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	431.66	15.10	31.92
mesenchymal precursor cell - cardiac, donor2	11753-123G7	350.80	7.94	34.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	224.02	8.49	20.16
mesenchymal precursor cell - cardiac, donor4	11755-123G9	169.21	8.24	17.83
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	124.76	3.98	15.08
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	185.76	8.23	28.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	154.15	6.64	14.67
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	569.01	20.94	43.98
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	247.24	9.19	26.75
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	507.19	7.91	22.65
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	213.00	9.93	24.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	252.39	6.16	20.98
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	115.80	2.52	6.29
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	317.70	6.13	14.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	138.12	6.83	13.65
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	209.11	7.00	47.86
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	324.50	4.01	33.77
mesenchymal stem cell line:Hu5/E18	10568-108B1	176.41	9.68	22.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	274.92	11.42	33.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	293.90	13.30	37.86
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	304.95	12.30	40.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	326.26	16.64	40.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	287.60	16.00	36.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	328.64	12.52	43.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	331.28	10.22	34.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	300.74	12.51	34.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	434.73	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	310.63	19.61	50.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	330.63	14.28	39.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	337.93	12.02	44.22
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	274.26	21.27	34.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	300.41	12.75	30.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	339.37	16.38	27.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	307.56	16.75	31.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	322.66	24.61	38.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	325.39	15.49	41.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	286.14	12.67	36.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	323.01	10.18	52.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	376.89	15.99	47.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	320.57	13.90	45.80
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	312.14	15.94	45.48
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	260.24	12.59	56.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	339.77	12.92	48.68
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	324.17	19.07	52.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	311.90	16.01	42.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	355.79	9.75	37.77
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	405.79	27.05	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	362.29	19.00	43.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	449.76	16.90	48.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	472.82	25.79	58.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	586.79	3.99	55.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	964.29	27.55	103.32
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	885.03	26.08	100.24
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	843.70	18.27	131.88
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1339.40	27.71	140.90
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1372.75	31.48	124.37
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1526.48	46.78	108.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1988.07	23.65	149.02
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	1640.95	30.82	184.90
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1767.80	45.43	148.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1357.26	20.29	137.06
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1354.78	24.67	137.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1369.44	26.71	143.11
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	822.49	14.51	138.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	802.46	4.36	141.74
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	861.60	17.74	153.31
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	367.17	10.32	49.16
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	465.45	9.04	103.94
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	439.02	5.77	71.66
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	2075.93	34.33	133.74
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	2190.01	30.83	160.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	2372.38	42.78	180.30
mesodermal tumor cell line:HIRS-BM	10696-109G3	181.05	3.87	19.34
mesothelioma cell line:ACC-MESO-1	10493-107B7	120.48	1.18	34.26
mesothelioma cell line:ACC-MESO-4	10494-107B8	65.80	0.46	5.79
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	136.76	4.27	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	143.23	3.39	26.00
mesothelioma cell line:Mero-25	10850-111F4	43.12	4.31	11.80
mesothelioma cell line:Mero-41	10851-111F5	180.42	4.40	41.32
mesothelioma cell line:Mero-48a	10852-111F6	100.31	4.43	22.81
mesothelioma cell line:Mero-82	10853-111F7	136.40	2.10	23.65
mesothelioma cell line:Mero-83	10854-111F8	115.92	2.72	17.87
mesothelioma cell line:Mero-84	10855-111F9	137.76	1.26	26.04
mesothelioma cell line:Mero-95	10856-111G1	307.87	11.18	46.17
mesothelioma cell line:NCI-H2052	10847-111F1	324.34	9.11	36.11
mesothelioma cell line:NCI-H226	10846-111E9	80.18	1.45	10.68
mesothelioma cell line:NCI-H2452	10848-111F2	133.75	1.54	23.74
mesothelioma cell line:NCI-H28	10845-111E8	43.51	1.27	17.56
mesothelioma cell line:No36	10857-111G2	153.97	2.28	28.05
mesothelioma cell line:ONE58	10858-111G3	99.71	1.08	14.90
migratory langerhans cells, donor1	11901-125F2	57.00	5.76	4.03
migratory langerhans cells, donor2	11902-125F3	32.36	6.59	5.62
migratory langerhans cells, donor3	11903-125F4	81.66	7.90	12.74
mixed mullerian tumor cell line:HTMMT	10689-109F5	395.69	17.96	73.46
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	80.54	3.39	61.67
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.29	2.07	7.60
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	37.87	1.33	16.94
myelodysplastic syndrome cell line:SKM-1	10772-110F7	923.22	35.11	42.69
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	193.28	4.06	16.74
myxofibrosarcoma cell line:NMFH-1	10684-109E9	311.86	19.81	46.29
nasal epithelial cells, donor1, tech_rep1	12226-129F3	164.80	2.67	16.27
nasal epithelial cells, donor1, tech_rep2	12226-129F3	172.75	2.50	22.06
nasal epithelial cells, donor2	12227-129F4	255.57	7.18	17.66
neuroblastoma cell line:CHP-134	10508-107D4	5.52	0.00	2.76
neuroblastoma cell line:NB-1	10539-107G8	94.48	3.37	44.15
neuroblastoma cell line:NBsusSR	10607-108F4	41.55	1.27	20.46
neuroblastoma cell line:NH-12	10555-107I6	34.29	0.56	10.06
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	6.64	0.47	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	91.07	1.90	64.94
neuroectodermal tumor cell line:TASK1	10774-110F9	30.99	1.21	9.26
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	155.71	3.73	30.88
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	18.94	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.18	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	133.68	4.80	88.86
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	334.39	9.94	122.15
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	377.33	8.67	44.67
nucleus accumbens, adult, pool1	10037-101F1	3094.14	6.94	18.28
occipital cortex - adult, donor10196	10172-103C1	2122.20	2.06	14.42
occipital cortex, adult, donor10252	10163-103B1	2381.72	6.71	17.18
occipital cortex, newborn, donor10223	10355-105E4	1523.83	4.73	10.92
occipital lobe, adult, donor1	10076-102A4	4235.64	7.87	19.16
occipital lobe, fetal, donor1	10073-102A1	207.68	0.86	21.03
occipital pole, adult, pool1	10036-101E9	3853.06	5.28	17.27
olfactory region, adult	10195-103E6	2101.38	18.72	19.30
optic nerve, donor1	10277-104E7	420.22	4.00	36.02
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	114.02	2.28	13.90
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	282.88	6.59	32.84
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	176.44	4.91	18.12
oral squamous cell carcinoma cell line:SAS	10544-107H4	151.20	3.93	13.28
osteoclastoma cell line:Hs 706.T	10704-109H2	123.17	16.76	44.98
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.05	6.54	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	97.76	7.85	18.87
ovary, adult, pool1	10020-101D2	785.81	6.46	84.38
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	29.15	2.20	9.17
pancreas, adult, donor1	10049-101G4	571.91	10.35	339.57
pancreatic carcinoma cell line:NOR-P1	10698-109G5	21.52	0.56	11.18
papillary adenocarcinoma cell line:8505C	10437-106E5	321.46	3.75	45.48
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	167.07	2.98	25.33
paracentral gyrus, adult, pool1	10035-101E8	2914.61	4.48	15.10
parietal cortex, adult, donor10258	10373-105G4	1534.81	4.40	7.34
parietal lobe - adult, donor10196	10171-103B9	2118.91	1.88	15.05
parietal lobe, adult, donor10252	10157-103A4	1832.79	3.99	10.55
parietal lobe, adult, pool1	10034-101E7	3073.61	4.93	14.98
parietal lobe, fetal, donor1	10072-101I9	450.00	0.97	18.43
parietal lobe, newborn, donor10223	10356-105E5	1277.85	6.73	14.95
parotid gland, adult	10199-103F1	3897.32	9.25	258.38
penis, adult	10200-103F2	968.41	4.83	86.48
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.22	0.00	5.95
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	110.58	0.73	32.64
pineal gland - adult, donor10196	10179-103C8	399.27	13.55	69.02
pineal gland, adult, donor10252	10160-103A7	408.03	7.70	50.93
pineal gland, adult, donor10258	10377-105G8	737.44	20.69	72.74
pituitary gland - adult, donor10196	10180-103C9	396.63	7.08	146.71
pituitary gland, adult, donor10252	10162-103A9	340.85	8.86	138.63
pituitary gland, adult, donor10258	10378-105G9	279.21	14.47	154.93
placenta, adult, pool1	10021-101D3	387.76	6.88	61.38
plasma cell leukemia cell line:ARH-77	10840-111E3	10.06	0.53	3.71
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	858.66	18.83	50.74
pons, adult, pool1	10033-101E6	1317.09	3.79	13.94
postcentral gyrus, adult, pool1	10032-101E5	3568.79	7.32	15.60
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	305.13	82.15	11.74
prostate cancer cell line:DU145	10490-107B4	75.16	1.60	16.46
prostate cancer cell line:PC-3	10439-106E7	157.54	4.36	39.93
prostate, adult, pool1	10022-101D4	811.06	18.41	108.47
putamen, adult, donor10196	10176-103C5	2539.57	5.19	11.09
putamen, adult, donor10252	10152-102I8	3050.89	15.69	21.57
putamen, adult, donor10258, tech_rep1	10372-105G3	1037.08	7.65	10.93
putamen, adult, donor10258, tech_rep2	10372-105G3	2555.29	7.01	9.66
putamen, newborn, donor10223	10365-105F5	1113.25	3.00	12.74
rectal cancer cell line:TT1TKB	10469-106I1	130.34	1.16	13.09
rectum, fetal, donor1	10067-101I4	306.02	6.95	61.20
renal cell carcinoma cell line:OS-RC-2	10411-106B6	215.39	4.03	62.75
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	176.87	4.56	75.80
retina, adult, pool1	10030-101E3	5535.46	20.87	121.47
retinoblastoma cell line:Y79	10475-106I7	28.06	1.04	12.73
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.42	0.37	11.31
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	107.42	1.41	17.43
sacrococcigeal teratoma cell line:HTST	10695-109G2	167.49	3.03	18.19
salivary acinar cells, donor1	11771-123I7	301.38	7.28	30.59
salivary acinar cells, donor2	11772-123I8	431.24	6.06	37.86
salivary acinar cells, donor3	11773-123I9	293.95	6.62	14.57
salivary gland, adult, pool1	10093-102C3	9573.34	24.59	142.42
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.91	0.84	6.41
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.98	1.76	10.11
seminal vesicle, adult	10201-103F3	565.58	8.99	112.16
serous adenocarcinoma cell line:JHOS-2	10639-108I9	97.17	2.43	20.41
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	279.31	20.38	60.64
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	200.71	11.04	35.12
serous cystadenocarcinoma cell line:HTOA	10693-109F9	573.28	2.55	42.58
signet ring carcinoma cell line:Kato III	10436-106E4	237.97	8.95	24.98
signet ring carcinoma cell line:NUGC-4	10483-107A6	303.47	4.39	30.32
skeletal muscle - soleus muscle, donor1	10282-104F3	612.87	4.97	11.35
skeletal muscle, adult, pool1	10023-101D5	942.11	6.72	43.06
skeletal muscle, fetal, donor1	10066-101I3	277.38	5.03	47.24
skin, adult, donor1	10074-102A2	1357.04	13.57	156.06
skin, fetal, donor1	10065-101I2	317.51	1.26	49.24
small cell cervical cancer cell line:HCSC-1	10800-110I8	195.44	1.67	40.69
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	161.39	5.99	39.09
small cell lung carcinoma cell line:DMS 144	10841-111E4	47.99	0.39	17.35
small cell lung carcinoma cell line:LK-2	10541-107H1	53.07	0.99	12.86
small cell lung carcinoma cell line:NCI-H82	10842-111E5	26.06	0.48	13.99
small cell lung carcinoma cell line:WA-hT	10562-108A4	42.49	1.09	12.42
small intestine, adult, pool1	10024-101D6	1219.63	19.11	128.28
small intestine, fetal, donor1	10064-101I1	730.95	13.27	96.80
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	867.32	20.52	176.44
smooth muscle, adult, pool1	10048-101G3	862.72	7.75	99.76
somatostatinoma cell line:QGP-1	10781-110G7	110.42	3.75	91.40
spinal cord - adult, donor10196	10181-103D1	1982.07	12.85	52.76
spinal cord, adult, donor10252	10159-103A6	2043.11	11.43	33.91
spinal cord, adult, donor10258	10369-105F9	1677.61	12.45	34.59
spinal cord, fetal, donor1	10056-101H2	5245.80	21.95	126.24
spinal cord, newborn, donor10223	10359-105E8	1588.42	6.89	46.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	168.77	7.77	37.04
spleen, adult, pool1	10025-101D7	1003.87	28.63	50.88
spleen, fetal, pool1	10044-101F8	734.80	13.83	35.60
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.32	0.31	3.11
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	94.37	0.76	17.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	224.70	1.75	26.21
squamous cell carcinoma cell line:T3M-5	10616-108G4	439.02	11.73	27.37
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.38	1.80	9.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	108.44	0.42	22.03
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	85.04	2.96	20.73
stomach, fetal, donor1	10062-101H8	405.83	6.41	85.44
submaxillary gland, adult	10202-103F4	5776.56	13.67	164.07
substantia nigra - adult, donor10196	10178-103C7	1248.31	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	1434.00	11.63	23.68
substantia nigra, adult, donor10258	10371-105G2	3123.16	9.83	23.28
substantia nigra, newborn, donor10223	10358-105E7	2988.11	13.42	25.44
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.09	1.15	12.15
temporal lobe, adult, pool1	10031-101E4	4507.42	8.99	22.13
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	408.84	0.71	24.93
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	424.59	3.96	15.82
tenocyte, donor1	11763-123H8	487.69	24.79	89.37
tenocyte, donor2	11765-123I1	655.05	26.71	133.91
tenocyte, donor3	11768-123I4	715.75	20.39	80.06
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	52.69	1.02	13.77
teratocarcinoma cell line:NCR-G1	10798-110I6	80.77	1.39	28.98
teratocarcinoma cell line:PA-1	10807-111A6	41.22	1.08	17.20
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	108.29	1.90	20.57
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.32	0.76	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	107.75	1.20	7.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.38	0.33	1.63
testis, adult, pool1	10026-101D8	1792.16	13.74	150.21
testis, adult, pool2	10096-102C6	2047.02	26.16	93.37
thalamus - adult, donor10196	10168-103B6	2689.31	9.94	33.12
thalamus, adult, donor10252	10154-103A1	2061.21	8.44	16.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	2411.04	18.48	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	1853.91	10.21	33.43
thalamus, newborn, donor10223	10366-105F6	3964.53	12.66	14.38
throat, adult	10209-103G2	1361.95	11.73	57.67
throat, fetal, donor1	10061-101H7	293.43	4.57	72.52
thymic carcinoma cell line:Ty-82	10803-111A2	20.67	0.99	6.36
thymus, adult, pool1	10027-101D9	984.01	7.85	16.60
thymus, fetal, pool1	10043-101F7	669.98	8.94	21.92
thyroid carcinoma cell line:KHM-5M	10776-110G2	312.19	19.41	39.76
thyroid carcinoma cell line:TCO-1	10783-110G9	231.61	7.26	32.41
thyroid, adult, pool1	10028-101E1	856.24	6.16	141.00
thyroid, fetal, donor1	10060-101H6	443.48	6.33	123.92
tongue epidermis (fungiform papillae), donor1	10288-104F9	702.15	15.40	40.04
tongue, adult	10203-103F5	760.76	9.54	44.19
tongue, fetal, donor1	10059-101H5	509.17	5.52	70.54
tonsil, adult, pool1	10047-101G2	748.61	16.03	73.13
trachea, adult, pool1	10029-101E2	793.20	16.11	111.00
trachea, fetal, donor1	10058-101H4	558.58	3.46	89.25
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	265.71	6.02	44.28
transitional-cell carcinoma cell line:5637	10418-106C4	94.83	14.79	17.02
transitional-cell carcinoma cell line:JMSU1	10492-107B6	17.08	0.78	5.17
tridermal teratoma cell line:HGRT	10694-109G1	79.91	1.90	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	79.40	1.61	18.54
umbilical cord, fetal, donor1	10057-101H3	271.25	8.35	54.25
uterus, adult, pool1	10100-102D1	673.13	13.31	48.12
uterus, fetal, donor1	10055-101H1	209.89	7.17	55.29
vagina, adult	10204-103F6	922.13	3.88	87.88
vein, adult	10191-103E2	1210.63	10.08	41.21
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.42	1.34	4.27